share_log

AbbVie | 8-K: The Impact of Acquired IPR&D and Milestones Expense

SEC announcement ·  Jul 6, 2023 16:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more